Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03936309 · ClinicalTrials.gov registry record · NA

A Comparison of Scar Infiltration, Scar Deactivation, and Standard of Care for the Treatment of Chronic, Post-Surgical Pain After Cesarean Section

A NA study of Scar and Cesarean Section; Dehiscence, sponsored by Jennifer Loomis.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT03936309 is a NA study of Scar and Cesarean Section; Dehiscence that has completed, run by Jennifer Loomis. The registered enrollment target is 60 participants, above the 45-participant average among 15 other Scar trials with a reported enrollment target (33% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03936309, a NA study of Scar and Cesarean Section; Dehiscence, has completed, sponsored by Jennifer Loomis.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

To compare scar infiltration with 0.5-1% Lidocaine at a dose of 3 mg/kg (max dose 300 mg) or scar deactivation with acupuncture surface release technique to determine which is more effective in reducing pain in adult patients with chronic, post-surgical pain related to the site of incision after low transverse Cesarean section compared to standard of care physical therapy with the McKenzie Method.

Conditions Studied

Scar Cesarean Section; Dehiscence

Interventions

  • OTHER Physical therapy
  • OTHER Scar Deactivation Surface Release Technique protocol
  • OTHER Scar Infiltration with 0.25-1% Lidocaine

Study Locations (1)

Illinois

  • 375th Medical Group - Scott Air Force Base

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2019-06-01
Est. Completion 2025-04-08
Phase NA

Sponsor

Jennifer Loomis

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03936309

The ClinicalTrials.gov registry entry for NCT03936309 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 45-participant average among 15 other Scar trials with a reported enrollment target (33% higher). The listed sponsor is Jennifer Loomis, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Scar appearing as the primary indexed condition, and to 3 interventions - of which Physical therapy is the first listed.

NCT03936309 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT03936309 about?

NCT03936309 is a clinical study titled "A Comparison of Scar Infiltration, Scar Deactivation, and Standard of Care for the Treatment of Chronic, Post-Surgical Pain After Cesarean Section". To compare scar infiltration with 0.5-1% Lidocaine at a dose of 3 mg/kg (max dose 300 mg) or scar deactivation with acupuncture surface release technique to determine which is more effective in reducing pain in adult patients with chronic, post-surgical pain related to the site of incision after low...

What is the current status of trial NCT03936309?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2019-06-01. Estimated completion is 2025-04-08.

What conditions does trial NCT03936309 study?

This clinical trial studies the following conditions: Scar, Cesarean Section; Dehiscence.

What interventions are being tested in trial NCT03936309?

The interventions under investigation include: Physical therapy (OTHER), Scar Deactivation Surface Release Technique protocol (OTHER), Scar Infiltration with 0.25-1% Lidocaine (OTHER).

Who is sponsoring clinical trial NCT03936309?

This trial is sponsored by Jennifer Loomis, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03936309 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Scar

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Scar

All registered trials for this condition

Cesarean Section; Dehiscence

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.